Endovascular

Implementation Science in PAD: Can We Do Better?

BEST-CLI and BASIL 2: How Should Findings Impact Care?

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

LIFE-BTK: The Top Line Results and Beyond

Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE)

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

FDA Opinion About Lessons Learned From the Paclitaxel Controversy

Patient-Level Meta-analysis on Paclitaxel Safety

Vascular Drug Delivery: Distilling the Paclitaxel Controversy

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Opportunities to Improve Outcomes: IVUS

Clinical RV Assessment in PE: Is it Hocus Pocus or Can We Standardize Echo Parameters?

Hemodynamics of PE: Modeling the RV

PE Risk Stratification in 2022

What Do the Patients With CLTI Look Like Today? Insights From LIFE-BTK and BEST CLI

Limb Perfusion Technology: Do We Have It Figured Out?

Have We Gotten to the Final Word on Paclitaxel Safety?

Management of Coronary Artery Disease in CLTI? Is That the Ticket?

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond